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Background: Constipation is one of the most common gastrointestinal complaints with a highly prevalent and
often chronic functional gastrointestinal disorder affecting health-related quality of life. The aim of the present
study was to evaluate the effects of Salecan on fecal output and small intestinal transit in normal and two models
of drug-induced constipation mice.
Methods: ICR mice were administrated intragastrically (i.g.) by gavage with 100, 200 and 300 mg/kg body weight
(BW) of Salecan while the control mice were received saline. The constipated mice were induced by two types of
drugs, loperamide (5 mg/kg BW, i.g.) and clonidine (200 μg/kg BW, i.g.), after Salecan treatment while the control
mice were received saline. Number, weight and water content of feces were subsequently measured. Small
intestinal transit was monitored by phenol red marker meal.
Results: Salecan (300 mg/kg BW) significantly increased the number and weight of feces in normal mice. In two
models of drug-induced constipation, Salecan dose-dependently restored the fecal number and fecal weight. The
water content of feces was markedly affected by loperamide, but not by clonidine. Treatment with Salecan
significantly raised the fecal water content in loperamide-induced constipation mice. Moreover, Salecan markedly
stimulated the small intestinal transit in both loperamide- and clonidine-induced constipation model mice.
Conclusions: These results suggest that Salecan has a potential to be used as a hydrophilic laxative for constipation.
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Constipation, defined as infrequent or difficult evacuation
of feces [1], is a worldwide functional gastrointestinal dis-
order. A systematic review recorded prevalence rates in six
different population groups from Asia ranging widely from
11.6% to 29.6% [2]. In general, constipation appears to be
more common in the elderly, women, nonwhites, and per-
sons in lower socio-economic and education classes [3].
Constipation also significantly impacts health-related qual-
ity of life in constipated people [4]. A primary mechanism
for slow-transit constipation is a failure of peristalsis to
move luminal contents through the colon results in more
time for bacterial degradation of stool solids and more time
for salt and water absorption, thus reducing stool fre-
quency and stool weight dramatically [5]. Medical therapy
for constipation contains traditional laxatives and agents.* Correspondence: jfzhang@mail.njust.edu.cn
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reproduction in any medium, provided the orThe former can induce defecation or modify stool
consistency to make defecation easier, while the latter tar-
gets presumed defects in colonic neuromuscular function
[5,6]. Although a common problem, the treatment of con-
stipation has been far from satisfactory [7].
Beta-glucans, naturally occurring polysaccharides with
poly-branched beta-(1→3)-D-glucans or beta-(1→6)-D-
glucose side chains, are a major component of the bran of
cereal plant and the cell wall of bacteria and fungi [8,9]. A
number of studies demonstrate beta-glucans may be bene-
ficial in gastrointestinal disease prevention and health pro-
motion, including reduction of cholesterol absorption and
bile acids excretion [10], fermentation by intestinal bac-
teria that yields short chain fatty acids [11], resistance to
enteric bacterial and viral infections [12,13], stimulation
autochthonous Lactobacillus populations in the colon
[14], and prevention of colorectal cancer by effecting im-
mune and cancer cells [15]. In addition, early observers
suggest that a decreasing prevalence of constipation istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.









0.4 g/60 ml H20 3260 mPa·s
0.8 g/60 ml H20 7850 mPa·s
1.2 g/60 ml H20 9500 mPa·s
Water holding capacity 9.7 g/g H20
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ing on their ability to avoid digestion and absorption in
small intestine and to escape bacterial metabolism in colon
[16]. Cummings [17] has tabulated the efficacy of different
fibers in terms of increased fecal weight per gram of ad-
ministered fiber, including wheat bran, psyllium, cellulose,
oats, corn, legumes, and pectin. Psyllium polysaccharide
from Plantago ovate is approved by the FDA for its proven
laxative effects as available fiber supplements [18,19].
Salecan, produced by Agrobacterium sp. ZX09, is a novel
high molecular, water-soluble extracellular polysaccharide,
and its structure is proven to consist of the following re-
peating unit:→3)-β-D-Glcp-(1→3)-[ β-D-Glcp-(1→3)-β-
D-Glcp-(1→3)]3-α-D-Glcp-(1→3)-α-D-Glcp-(1→ [20].
As a new beta-glucan with special molecular structure, its
safety has been demonstrated in the acute and subchronic
experiment [21]. Supplementation with Salecan reduced
adiposity and improved glucose tolerance in high-fat diet-
fed mice through disturbing bile acid-promoted emulsifi-
cation in intestine [22]. Its rheology study indicates that
Salecan has a non-Newtonian viscosity behavior, and
could be utilized in the food industry [23]. In the present
study, we estimated the laxative effects of Salecan on fecal
output and small intestinal transit in normal and two
models of drug-induced constipation mice. Our results




Salecan was prepared according to previous methods
[20]. Briefly, Agrobacterium sp. ZX09 used in this study
was isolated from a soil sample from the ocean coast of
Shandong, China. Cultures were maintained on Htm
agar containing NaH2PO4 (1 g) , KNO3 (3 g), CaCl2
(0.07 g), MgCl2 (0.2 g), FeSO4·7H2O (0.0125 g), MnSO4
(0.003 g), ZnCl2 (0.0075 g), sucrose (20 g), agar (9 g) and
H2O (1000 ml), pH 7.2. A colony of the strain ZX09 was
inoculated into a 250 ml flask containing 50 ml medium
consisting of 2 % sucrose and mineral salt solution. The
inoculated preparation was incubated at 28°C on a rotary
shaker at 220 rpm for 24 h. A 0.5 ml portion was trans-
ferred to a 250 ml flask containing 50 ml fermentation
medium. Fermentation was performed on a rotary
shaker at 220 rpm for 48 h. The culture broth was di-
luted more than 3 times with de-ionized water and
centrifuged at 12 000 × g for 30 min to separate cells
from the supernatant. The supernatant was added to
two volumes of 95 % ethanol. Productivity of Salecan
was expressed in terms of the weight after ethanol pre-
cipitation collected by centrifugation at 6000 × g for 15
min and dried under reduced pressure. The chemical
composition, solution viscosity and water holding cap-
acity (WHC) of Salecan were shown in Table 1.Animals
Male ICR mice (8 weeks old) were purchased from SLAC
(Shanghai Laboratory Animal Center, Shanghai). All ani-
mals, used after 1 week of acclimation (temperature 22 ±
2°C; 12/12 h light/dark cycles), had free access to standard
lab chow and water. All animal procedures were approved
by the Institutional Animal Care and Use Committee of
Nanjing University of Science and Technology.
Fecal parameters measurements in normal mice
Mice, given food and water ad lib, were randomly divided
into four groups (n = 5 in each group): control and Salecan
(three groups of different dosage). After either Salecan
(100, 200 and 300 mg/kg BW, doses based on Maeda et al.
[24] and Shan et al. [25]) or saline was administered (i.g.),
the animals were immediately placed in clean transparent
cages individually and allowed access to their standard lab
chow and top water ad libitum. Then, feces for each
mouse were collected, counted and weighted at 0–8 h
period. The number and weight of feces were expressed in
terms of the total number and wet weight per mouse.
Fecal parameters measurements in two types of
constipation model mice
The number and weight of feces for each mouse in
loperamide- and clonidine-induced constipation model
mice were measured as the method of Kakino et al.
[26,27]. The mice, given food and water ad lib, were ad-
ministered (i.g.) saline or Salecan at 100, 200 or 300 mg/
kg BW, and then administered loperamide (5 mg/kg BW,
dissolved in 1% Tween 80/saline, i.g.) at 1 h after or cloni-
dine (200 μg/kg BW, dissolved in saline, i.g.) at 45 min
after Salecan treatment. Then, the experimental processes
were in accordance with Section 2.3. After weighted, the
wet feces for each mouse were dried at 105°C for 48 h.
The water content of feces was calculated as:fecal water
content (%) = (feces weight before dried - feces weight
after dried)/feces weight before dried × 100.
Figure 2 Effects of Salecan on number (A, B), weight (C) and water co
values are presented as mean ± SEM (n = 8). a p < 0.05 compared with con
constipated control.
Figure 1 Effects of Salecan on number (A) and weight (B) of
feces in normal mice. All values are presented as mean ± SEM
(n = 5). a p < 0.05 compared with control.
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Small intestinal transit (SIT) was determined using a
phenol red marker meal (0.5 ‰ phenol red indicator in
1.5 % methylcellulose; 10 ml/kg BW, i.g.), followed the
previous studies [26]. Administering of three doses of
Salecan and two models of constipation were in accordance
with Section 2.4. After fasted for 14 h with water ad
libitum, all mice were administered by i.g. with either
Salecan or saline at 1 h before loperamide or at 45 min be-
fore clonidine. After 30 min, a phenol red marker meal was
administered to experimental mice. After 20 min, the mice
were sacrificed by cervical dislocation under anesthesia with
diethyl ether. The small intestine from the pylorus to the
blind intestine was carefully removed. The SIT (%) for each
animal was calculated as: distance traveled by phenol red
marker meal/total length of the small intestine × 100.Statistics
All data are expressed as mean ± SEM. Differences be-
tween groups were analyzed by one-way analysis of vari-
ance (ANOVA) followed by the Tukey test. Differences
between means were considered statistically significant
at p < 0.05.Results
Increased fecal output in normal mice treated with Salecan
The effects of Salecan on number and weight of feces in
normal mice were shown in Figure 1. Compared with the
control, treatment with Salecan (300 mg/kg BW)ntent (D) of feces in loperamide-induced constipation mice. All
trol; b p < 0.05 compared with LP. LP, loperamide-treated group as
Figure 3 Effects of Salecan on number (A), weight (B) and water
content (C) of feces in clonidine-induced constipation mice. All
values are presented as mean ± SEM (n = 8). a p < 0.05 compared with
control; b p < 0.05 compared with CL. CL, clonidine-treated group as
constipated control.
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(Figure 1A) and fecal weight (Figure 1B).Salecan improved fecal output character in two types of
constipation mice
A model of spastic constipation was induced by lopera-
mide. Loperamide obviously reduced number, weight and
water content of feces (Figure 2). Salecan counteracted the
decrease in number and weight of feces induced by lo-
peramide (Figure 2A, B, C). The effect was significant
starting from the 200 mg/kg BW oral dose. There was a
significant restoration of fecal water content in Salecan
group at 300 mg/kg (95.14 ± 1.68% of control) compared
with the LP group (85.81 ± 2.77% of control) (Figure 2D).Figure 4 Effects of Salecan on small intestinal transit in
loperamide- (A) and clonidine-induced (B) constipation mice. All
values are presented as mean ± SEM (n = 8). a p < 0.05 compared
with control; b p < 0.05 compared with LP or CL. LP, loperamide-
treated group as constipated control; CL, clonidine-treated group as
constipated control.
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dine. Clonidine significantly reduced the fecal number
from ~19 to ~7 and fecal weight from ~0.5 g to ~0.24 g
(Figure 3A, B). Salecan at a dose of 300 mg/kg obviously
increased the fecal number and fecal weight to ~15 and
~0.43 g, respectively (Figure 3A, B). There was no signifi-
cant difference between the groups in fecal water content
(Figure 3C).
Effects of Salecan on the SIT
After loperamide or clonidine administration, the SIT
were significantly inhibited (Figure 4). The treatment
with Salecan increased the SIT in a dose dependent
manner in both loperamide- and clonidine-induced con-
stipation model mice (Figure 4).
Discussion
Constipation is a highly prevalent functional gastrointes-
tinal disorder, affecting the quality of life in constipated
persons [7], and the use of dietary fiber in the prevention
and treatment of constipation is a common practice in
many countries of the world [16,28]. The present study has
evaluated laxative effects of Salecan on normal as well as
on loperamide- and clonidine-induced constipation mice.
As an agent for functional bowel disorders like diar-
rhea, loperamide used as constipation inducer is well
documented. The drug inhibits intestinal fluid secretion
and intestinal motility, leading to delay fecal evacuation
time and intestinal luminal transit [29], and is used to in-
duce a model of spastic constipation. On the other hand,
clonidine also has a potent antidiarrheal effect, and has a
suppressive effect on gastrointestinal contractions [30].
This drug can cause a model of atonic constipation. The
observed decrease in the number and weight of feces by
the treatment with these two drugs indicated induction of
constipation in mice. Similar observation was reported by
Kakino et al. [27].
Salecan is an identified extracellular macromolecule
from Agrobacterium sp. ZX09, mainly composed of β-
(1→3)-D-glucosidic linkages as the main backbone
structure, together with a small portion of α-(1→3)-D-
glucosidic linkages [20]. Salecan is a non-toxic and water-
soluble beta-glucan with excellent rheological properties
[21,23]. Bacterial extracellular polysaccharides (e.g. dex-
tran) can be easily produced and applied in food industry
[31]. Beta-glucans are not digestible due to a lack of the
hydrolase in gastrointestinal tract. Furthermore, Salecan
increased fecal weight and fecal number in normal mice
in present study. Similar observation was reported by
Nakamura et al. [32] where brewer’s yeast cell wall, which
was composed mainly of polysaccharides, significantly in-
creased fecal frequency and weight in normal rats. Due to
these properties, it is presumed that Salecan has favorable
effects on prevention of constipation.The effects of Salecan on constipation in this study
were tested in loperamide- and clonidine-induced consti-
pation mice. The administration of Salecan to the consti-
pated mice was effective in increasing the fecal number
and fecal weight, which were indications of the laxative
character of Salecan. Unlike clonidine, loperamide also
markedly decreased the water content of feces through
inhibition of intestinal fluid secretion. Treatment with
Salecan significantly raised the fecal water content in
loperamide-induced constipation mice. And the SIT time
was shortened by the treatment with Salecan in both
constipation models. The laxative effectiveness of dietary
fibers, as bulk agents, depends on their WHC and swell-
ing force [5]. Salecan was proved to have a high WHC. It
may thus be concluded that the fecal output character
was affected by the WHC and swelling force of Salecan
in small intestine. This swelling force serves as a stimulus
to defecation. Xu et al. [33] reported that supplementa-
tion of the diet with partially defatted flaxseed meal
markedly decreased gastrointestinal transit time as well
as increased fecal frequency and weight in constipated
mice, which was dependent on luminal bulk. In addition,
given the fact that soluble fibers may delay nutrients di-
gestion and absorption by absorbing large quantities of
water and forming gels in the gastrointestinal tract [34],
Salecan might be possible to prevent the absorption of
loperamide and clonidine in this results.
Conclusion
Our results demonstrate that Salecan, as a new structural
glucan, alleviates the symptom of loperamide- and clonidine-
induced constipation. Because of its easy availability,
Salecan could be recommended as a cost-effective alterna-
tive for constipation.
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